bioAffinity Technologies (BIAFW) EBITDA Margin (2022 - 2026)
bioAffinity Technologies (BIAFW) reported EBITDA Margin of 265.82% for Q1 2026, down 12644.0% year-over-year from N/an in Q1 2025, and down 36.6% quarter-over-quarter from 194.59% in Q4 2025.
bioAffinity Technologies (BIAFW) EBITDA Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 5 years of EBITDA Margin data on file, last reported at 265.82% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 265.82%, down 12644.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 201.62% (down 9414.0% YoY), and the FY2025 annual result was 168.81%, down 7491.0% from the prior year.
- EBITDA Margin slipped to 265.82% in Q1 2026 per BIAFW's latest filing, from 194.59% in the prior quarter.
- Over five years, EBITDA Margin peaked at 79.22% in Q1 2024 and troughed at 166806.19% in Q1 2023.
- A 5-year average of 23999.31% and a median of 194.62% in 2025 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2026: EBITDA Margin soared 16672697 bps in 2024, then plunged 12644 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 68902.77% in 2022, then surged by 100 bps to 98.32% in 2023, then slumped by 34 bps to 131.53% in 2024, then slumped by 48 bps to 194.59% in 2025, then sank by 37 bps to 265.82% in 2026.
- Business Quant data shows BIAFW's EBITDA Margin at 265.82% in Q1 2026, 194.59% in Q4 2025, and 155.47% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.21% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 19.42% |
| 10 | bioAffinity Technologies | - | - | - | -265.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.82% |
| Dec 31, 2025 | -194.59% |
| Sep 30, 2025 | -155.47% |
| Jun 30, 2025 | -194.65% |
| Mar 31, 2025 | -139.37% |
| Dec 31, 2024 | -131.53% |
| Sep 30, 2024 | -82.26% |
| Jun 30, 2024 | -85.40% |
| Mar 31, 2024 | -79.22% |
| Dec 31, 2023 | -98.32% |
| Sep 30, 2023 | -753.61% |
| Jun 30, 2023 | -8,903.38% |
| Mar 31, 2023 | -166,806.19% |
| Dec 31, 2022 | -68,902.77% |
| Sep 30, 2022 | -84,813.57% |
| Jun 30, 2022 | -52,382.77% |